{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-052467","form_type":"8-K","ticker":"QSI","cik":"0001816431","company_name":"Quantum-Si Inc","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.625766+00:00","generated_at":"2026-06-08T07:25:19.943830+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Quantum-Si Q3 2023: $223k revenue, $24.7M net loss; controlled launch continues","bullets":["Revenue of $223,000; gross profit $108,000 (48% margin); net loss $24.7M vs. $31.7M YoY.","Adjusted EBITDA loss of $22.6M; adjusted operating expenses $23.9M.","Completed R&D strategic review; focused on delivering capabilities with highest customer demand.","First customer data presented; full commercial launch of Platinum instrument expected early 2024.","Appointed Amir Jafri as independent director, strengthening Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-052467","json":"https://secwatch.observer/filing/0001140361-23-052467.json","markdown":"https://secwatch.observer/filing/0001140361-23-052467.md","text":"https://secwatch.observer/filing/0001140361-23-052467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123052467/0001140361-23-052467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123052467/ef20014055_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:25:19.943830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b1cf4181acc94deabf53760e355d8bf5638d7d11","claim":"Quantum-Si Inc reported the third quarter ended September 30, 2023 results: revenue revenue of $223,000, net income Net loss was $24.7 million.","evidence_excerpt":"“Company”), The Protein Sequencing Company TM , today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights ● Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum instrument ● Completed a strategic review of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123052467/0001140361-23-052467-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"revenue of $223,000"},{"label":"Net income","value":"Net loss was $24.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}